Sorafenib in combination with gemcitabine plus cisplatin chemotherapy in metastatic renal collecting duct carcinoma: A prospective, multicentre, single-arm, phase 2 study
about
Sorafenib in combination with gemcitabine plus cisplatin chemotherapy in metastatic renal collecting duct carcinoma: A prospective, multicentre, single-arm, phase 2 study
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Sorafenib in combination with ...... tre, single-arm, phase 2 study
@en
type
label
Sorafenib in combination with ...... tre, single-arm, phase 2 study
@en
prefLabel
Sorafenib in combination with ...... tre, single-arm, phase 2 study
@en
P2093
P1476
Sorafenib in combination with ...... tre, single-arm, phase 2 study
@en
P2093
Bixia Tang
Chuanliang Cui
Dengfeng Cao
Fangjian Zhou
Jianlin Yuan
P356
10.1016/J.EJCA.2018.04.007
P50
P577
2018-06-19T00:00:00Z